Trial intelligence / Profile preview

Topical NSAID therapy for osteoarthritis (Loxoprofen vs Flurbiprofen)

ChiCTR2100050164Phase 4Not yet recruiting

Sponsor
Union Hospital
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of loxoprofen and flurbiprofen in osteoarthritis (OA) (2 arms), sponsored by Union Hospital. Primary endpoint: Total effective rate of treatment. Planned start Apr 2021; status: not yet recruiting.

02

Drugs

loxoprofenflurbiprofen
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR2100050164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100050164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call